SECTION C
Pre Arrest
VISUALIZE
Post Arrest
P Provoke/precipitate Check Pulse and BP
Quality-sharp stabbing, crushing,
ROSC PETCO 35-45 mmHg
Q
burning,dull BP unstable- need to increase BP
V
VERBALIZE R Radiate/Region • Fluids (PNSS/PLRS) 1-2 liters
• 4 point auscultation – check for lung congestion
C
S Severity pain scale (1-10 )
Timing, start? Last?
• If lung is congested, consider DEN 10
T
• Dopamine 10 µg/kg (only µg/kg)
HR 60-100 • Epinephrine 2-10 µg
BP 90 systolic • Norepinephrine 2- 10µg
VITAL SIGNS
RR 16-20
No breathing
O2 Saturation 95-100 %
• Advance airway
O2 Saturation < 94 % • 1° do a 5 Point Auscultation – to check ET tube
O Nasal canula 2-4 liters placement
Face Mask 6-10 liters o If you heard bubling sound, the ET tube is on
NRB 11-15 liters ab the esophagus
o Remove ET tube, then reinsert
Monitor Pads on chest o Auscultate again
M
o If in place, do secondary survey
“White on the Right, Smoke over Fire” • 2° check wave form Capnograpy
“Snow over Grass, Smoke over Fire , and we burn some o Qualitative :yellow wave
chocolates” o Quantitative: 35-40 mmHg
Establishh Intravenous fluids Disability
I Intravenous Cubital vein • Conscious? Ask patient to squeeze your finger
After 2 failled attemps • No response → GCS 3
• Start THERAPEUTIC TEMPERATURE MGT.
d
consider
Intra osseous Humerus or tibia • PNSS/PLRS, 30cc/kg @ 4° C for 12-24 hours
TREATMENT • to maintain core body temperature of 32-36°C ,
0.5 mg (lowering the metabolic rate thus allowing the body
A Atropine maximum of 3 mg → 6 doses to recover)
T T
D
Transcutaneous pacemaker
Dopamine
infusion
Renal -2 µg/kg/min
Cardiac - 5µg/kg/min
NGT
Vasopressor- 10 µg/kg/min
Portable CXR 12 lead ECG
E Epinephrine Attach CVP
FAST
NCT (NARROW WCT (WIDE COMPLEX FOLEY CATHETER
COMPLEX TACHYCARDIA) REFER TO ICU FOR ADMISSION
TACHYCARDIA
Vagal maneuver/
Physiologic P stimulation
Adenosine 6-12
Amiodarone
Pharmacologic P mg Rapid IV P
150 mg
push
Diazepam/
Sedate S Midazolam 5mg
S Diazepam 5 mg
Synchronized AFIB 12O J
cardio version S SVT 50 J
S VTACH 100 J
Page 1 of 2 1
SECTION C
Page 2 of 2